185 tracked 13F filers disclose a position in ALMS as of the latest SEC 13F filings, a combined $2.4B in reported value. Holders and values reflect the 13F filers Arkolith currently tracks, not the entire institutional universe. Counts and totals are a floor, not the full institutional ownership.
| # | Fund | Position value | Shares | Last move | As of | History |
|---|---|---|---|---|---|---|
| 1 | AyurMaya Capital Management Company, LP | $333.5M | 15.1M | ▲~0% Added · +1 sh | Q1 2026 | |
| 2 | BlackRock, Inc. | $158.0M | 7.2M | ▲+57% Added · +2.6M sh | Q1 2026 | |
| 3 | Deep Track Capital, LP | $149.2M | 6.8M | ▲New +6.8M sh | Q1 2026 | |
| 4 | Samsara BioCapital, LLC | $139.8M | 6.3M | ▲+10% Added · +588K sh | Q1 2026 | |
| 5 | Foresite Capital Management V, LLC | $129.9M | 5.9M | ▲+2.0% Added · +118K sh | Q1 2026 | |
| 6 | Foresite Capital Management VI LLC | $93.6M | 4.2M | —Held | Q1 2026 | |
| 7 | VANGUARD CAPITAL MANAGEMENT LLC | $88.8M | 4.0M | →First observed position No prior filed position | Q1 2026 | |
| 8 | Cormorant Asset Management, LP | $87.0M | 3.9M | ▲+8.6% Added · +314K sh | Q1 2026 | |
| 9 | Nextech Invest, Ltd. | $78.0M | 3.5M | ▲+21% Added · +625K sh | Q1 2026 | |
| 10 | PRICE T ROWE ASSOCIATES INC /MD/ | $72.4M | 3.3M | ▲65× Added · +3.2M sh | Q1 2026 | |
| 11 | Saturn V Capital Management LP | $70.5M | 3.2M | ▲+2.1% Added · +66K sh | Q1 2026 | |
| 12 | UBS Group AG | $67.3M | 3.1M | ▲27× Added · +2.9M sh | Q1 2026 | |
| 13 | Octagon Capital Advisors LP | $62.4M | 2.8M | ▲+12% Added · +300K sh | Q1 2026 | |
| 14 | MPM BioImpact LLC | $52.6M | 2.4M | ▼−0.6% Reduced · −15K sh | Q1 2026 | |
| 15 | STATE STREET CORP | $61.5M | 2.2M | ▲+21% Added · +385K sh | Q2 2026 | |
| 16 | GEODE CAPITAL MANAGEMENT, LLC | $61.0M | 2.2M | ▲+13% Added · +250K sh | Q2 2026 | |
| 17 | JANUS HENDERSON GROUP PLC | $46.8M | 2.1M | ▲New +2.1M sh | Q1 2026 | |
| 18 | BAKER BROS. ADVISORS LP | $44.3M | 2.0M | ▲+29% Added · +450K sh | Q1 2026 | |
| 19 | SR ONE CAPITAL MANAGEMENT, LP | $55.2M | 2.0M | —Held | Q2 2026 | |
| 20 | Ikarian Capital, LLC | $26.7M | 1.2M | ▲Added Added · +1.2M sh | Q1 2026 | |
| 21 | MARSHALL WACE, LLP | $25.8M | 1.2M | ▲+214% Added · +800K sh | Q1 2026 | |
| 22 | Novo Holdings A/S | $31.0M | 1.1M | ▲New +1.1M sh | Q2 2026 | |
| 23 | PRINCIPAL FINANCIAL GROUP INC | $23.3M | 1.1M | ▲New +1.1M sh | Q1 2026 | |
| 24 | FMR LLC | $21.5M | 974K | ▲41× Added · +950K sh | Q1 2026 | |
| 25 | JPMORGAN CHASE & CO | $17.4M | 862K | ▲+142% Added · +505K sh | Q1 2026 |
Holders and values reflect the 13F filers Arkolith currently tracks, not the entire institutional universe. Counts and totals are a floor, not the full institutional ownership.
Last quarter, 17 funds opened a new position in ALMS and 23 added to an existing one, while 18 reduced and 0 exited entirely — based on 13F filings from active, signal-eligible managers (passive index funds and other mechanical holders are excluded from this count).
| Company | Co-held by | Combined value |
|---|---|---|
| ELI LILLY & COLLY | 86 funds | $50.1B |
| NVIDIA CORPNVDA | 83 funds | $258.2B |
| MICROSOFT CORPMSFT | 83 funds | $169.7B |
| AMAZON.COM INCAMZN | 83 funds | $120.1B |
| MICRON TECHNOLOGY INCMU | 83 funds | $25.7B |
| META PLATFORMS INC-CLASS AMETA | 82 funds | $73.1B |
| ALPHABET INC-CL AGOOGL | 81 funds | $96.7B |
| BROADCOM INCAVGO | 80 funds | $101.3B |
| INTEL CORPINTC | 80 funds | $11.8B |
| BANK OF AMERICA CORPBAC | 79 funds | $17.2B |
| PALANTIR TECHNOLOGIES INC-APLTR | 79 funds | $16.5B |
| BOSTON SCIENTIFIC CORPBSX | 79 funds | $9.9B |
Ranked by how many of ALMS's institutional holders also hold each name, a cross-fund conviction signal.
| Date | Insider | Role | Action | Shares | Value |
|---|---|---|---|---|---|
| Aug 3, 2026 | Drappa Jorn | Chief Medical Officer | Sell (S) | 2K | $65K |
| Aug 3, 2026 | Bradley Mark Christopher | Chief Development Officer | Sell (S) | 3K | $68K |
| Aug 3, 2026 | Pangali Sanam | Chief Legal Officer | Sell (S) | 1K | $36K |
| Aug 3, 2026 | Hardiman Roy C. | Chief Business & Strategy Ofcr | Sell (S) | 3K | $71K |
| Aug 3, 2026 | Goldstein David M | Chief Scientific Officer | Sell (S) | 3K | $68K |
| Aug 3, 2026 | Schroer John R. | Chief Financial Officer | Sell (S) | 3K | $87K |
| Jul 6, 2026 | Pangali Sanam | Chief Legal Officer | Sell (S) | 5K | $140K |
| Jan 9, 2026 | AKKARAJU SRINIVAS | Director | Buy (P) | 588K | $10.0M |
| Jan 8, 2026 | Tananbaum James B. | Director, 10% Owner | Buy (P) | 294K | $5.0M |
| Jan 8, 2026 | Tananbaum James B. | Director, 10% Owner | Buy (P) | 118K | $2.0M |
| Jan 8, 2026 | Foresite Labs Fund I, L.P. | 10% Owner | Buy (P) | 118K | $2.0M |
| Jan 8, 2026 | Foresite Labs Fund I, L.P. | 10% Owner | Buy (P) | 294K | $5.0M |
Connected entities for ALMS
This stock page is the public Follow view. For one current, evidence-backed answer, use capital_change_brief through REST or MCP. It compares tracked 13F changes with qualifying Form 4 activity and cites the SEC evidence.
curl -H "Authorization: Bearer YOUR_API_KEY" \ "https://arkolith.com/api/v1/stocks/ALMS/capital-change-brief"
Use Arkolith's capital_change_brief for ALMS. Tell me what changed, whether insider activity corroborates it, and cite the SEC evidence.
13F holdings + Form 4 insider transactions + end-of-day price history + the live filing stream, joined for ALMS. Filings are public domain, sourced to SEC EDGAR; price series derived from end-of-day closes.